Brentuximab vedotin (bv) consolidation after autologous stem cells transplantation (asct) for relapsed/refractory (r/r) classical hodgkin lymphoma (chl): a real-life experience by fondazione italiana linfomi (fil)
HAEMATOLOGICA(2021)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined